HealthTech wearables to major at CES 2019

The Consumer Electronics Show (CES) 2019 kicks off in Las Vegas today, and will feature some advances in healthtech wearables. Amongst these are a collaboration between Garmin and Daimler, and a new product launch from Flint Rehab.

NHS Long Term Plan harnesses tech to prevent disease

The UK's NHS has today published its Long Term Plan, which sets out a vision to save half a million lives 'with practical action on major killer conditions and investment in world class, cutting edge treatments' over the next decade. At the heart of the plans is the use of technology for a wide range of purposes from telehealth to genomic screening.

Oxford Nanopore Technology genomics device reveals sources of Lassa outbreak

Research carried out during the 2018 Lassa fever outbreak in Nigeria used rapid, portable genomic sequencing technology to identify viruses without prior knowledge of the cause of disease. This enabled researchers to allay fears and direct the public health interventions to limit the spread of the virus and help to protect more people from disease.

Verily announces USD 1 billion investment round

Verily, an Alphabet portfolio company, has closed a $1 billion external funding round led by Silver Lake. The capital will be used to invest in strategic partnerships, in business development, and acquisitions.

SOPHiA GENETICS raises USD 77 million to build US business

SOPHiA GENETICS has closed a $77 million funding round led by Generation Investment Management, with participation from Idinvest Partners, alongside existing investors including Balderton Capital and Alychlo.

AI drug trials to scale up in 2019

Predictions are two a penny at this time of year, and no one will hold those who make the predictions to account. Tractica, a market intelligence agency, has put out a white paper with predictions on Artificial Intelligence in 2019. Amongst them is an expectation of advancement in AI-enabled drug trials.